The GFAP fragments in the soluble fractions from a few personal ALS and non-ALS spinal cord samples had been immunoprecipitated with the antiGFAP antibody, and analysed by Western blotting utilizing the antibody towards acetyl-lysine (the correct panel)
Even so, a big limitation lies in the broad spectrum of poisonous facet consequences and even adverse effects. We hypothesize that the toxic side effects are owing to the non-specificity…